Correlation Between Cardiff Oncology and PDS Biotechnology
Can any of the company-specific risk be diversified away by investing in both Cardiff Oncology and PDS Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cardiff Oncology and PDS Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cardiff Oncology and PDS Biotechnology Corp, you can compare the effects of market volatilities on Cardiff Oncology and PDS Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cardiff Oncology with a short position of PDS Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cardiff Oncology and PDS Biotechnology.
Diversification Opportunities for Cardiff Oncology and PDS Biotechnology
0.22 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Cardiff and PDS is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Cardiff Oncology and PDS Biotechnology Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PDS Biotechnology Corp and Cardiff Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cardiff Oncology are associated (or correlated) with PDS Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PDS Biotechnology Corp has no effect on the direction of Cardiff Oncology i.e., Cardiff Oncology and PDS Biotechnology go up and down completely randomly.
Pair Corralation between Cardiff Oncology and PDS Biotechnology
Given the investment horizon of 90 days Cardiff Oncology is expected to generate 1.51 times more return on investment than PDS Biotechnology. However, Cardiff Oncology is 1.51 times more volatile than PDS Biotechnology Corp. It trades about 0.07 of its potential returns per unit of risk. PDS Biotechnology Corp is currently generating about -0.03 per unit of risk. If you would invest 149.00 in Cardiff Oncology on September 12, 2024 and sell it today you would earn a total of 229.00 from holding Cardiff Oncology or generate 153.69% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cardiff Oncology vs. PDS Biotechnology Corp
Performance |
| Timeline |
| Cardiff Oncology |
| PDS Biotechnology Corp |
Cardiff Oncology and PDS Biotechnology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cardiff Oncology and PDS Biotechnology
The main advantage of trading using opposite Cardiff Oncology and PDS Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cardiff Oncology position performs unexpectedly, PDS Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PDS Biotechnology will offset losses from the drop in PDS Biotechnology's long position.| Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. PDS Biotechnology Corp | Cardiff Oncology vs. Reviva Pharmaceuticals Holdings | Cardiff Oncology vs. Eyenovia |
| PDS Biotechnology vs. Mereo BioPharma Group | PDS Biotechnology vs. Terns Pharmaceuticals | PDS Biotechnology vs. Inozyme Pharma | PDS Biotechnology vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |